Pfizer patent blow after UK ruling on €4.4bn pain drug

By Ben Hirschler

Pfizer has lost the final round in a long-running patent battle in the UK after the country’s highest court ruled against it in a case involving its €4.4bn-a-year pain drug Lyrica.